- Home
- /
- Treatment
- /
- Page 134
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Purified type II collagen | Juvenile rheumatoid arthritis | AutoImmune, Inc.;128 Spring Street;Lexington, Massachusetts, 02421 | February 9, 1995 | |
Chondroitinase | Patients undergoing vitrectomy | Bausch & Lomb Pharmaceuticals, Inc.;8500 Hidden River Pkwy.;Tampa, Florida, 33637 | February 9, 1995 | |
Aminocaproic acid | For the topical treatment of traumatic hyphema of the eye | Eastern Virginia Medical School;Department of Ophthalomology, 880 Kempsville Road, Suite 2500;Norfolk, Virginia, 23502 | January 6, 1995 | |
Human immunodeficiency virus immune globulin | HIV-infected pediatric patients | NABI;5800 Park of Commerce Blvd., NW;Boca Raton, Florida, 33487 | January 4, 1995 | |
Coumarin | Renal cancer | Drossapharm LTD;4002 Basel; | December 22, 1994 | |
Somatostatin | Bleeding esophageal varices | Eumedica Pharmaceuticals A.G. (Schweiz);Arnold Bocklin-Strasse 1, CH-4051;BASEL | December 22, 1994 | |
Orgotein for injection | Amyotrophic lateral sclerosis | Oxis International, Inc.;6040 N. Cutter Circle, Suite 317;Portland, Oregon, 97217 | December 22, 1994 | |
Recombinant methionyl brain-derived neurotrophic factor | Amyotrophic lateral sclerosis | Amgen, Inc.;One Amgen Center Dr., M/S: 17-2-B;Thousand Oaks, California, 91320 | November 28, 1994 | |
Dimethyl sulfoxide | Increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available | Abela Pharmaceuticals, Inc.;21581 Midcrest Drive;Lake Forest, California, 92630 | November 22, 1994 | |
Soluble recombinant human complement receptor type 1 | Prevention or reduction of adult respiratory distress syndrome | T Cell Sciences, Inc.;119 Fourth Avenue;Needham Heights, Massachusetts, 02194 | November 21, 1994 | |
Sodium dichloroacetate | Lactic acidosis in patients with severe malaria | Stacpoole, Peter W. M.D., Ph.D.;University of Florida, P.O. Box 100277;Gainesville, Florida, 32610 | November 10, 1994 | |
Dapsone | Prophylaxis of toxoplasmosis in severely immunocompromised patients with CD4 counts below 100 | Jacobus Pharmaceutical Company, Inc.;37 Cleveland Lane, P.O. Box 5290;Princeton, New Jersey, 08540 | November 7, 1994 | |
Buprenorphine in combination with naloxone | Opiate addiction in opiate users | Indivior, Inc.;10710 Midlothian Turnpike, Suite 430;Richmond, Virginia, 23235 | October 27, 1994 | |
Melanoma cell vaccine | Invasive melanoma | CancerVax Corporation;2110 Rutherford Road;Carlsbad, California, 92008 | October 13, 1994 | |
Tobramycin for inhalation | Cystic fibrosis | Novartis Pharmaceuticals Corp;Drug Regulatory Affairs, One Health Plaza;East Hanover, New Jersey, 07936 | October 13, 1994 | |
Recombinant human luteinizing hormone | For use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism | EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 | October 7, 1994 | |
Coagulation Factor IX (recombinant) | Hemophilia B | Genetics Institute, Inc.;87 Cambridge Park Drive;Cambridge, Massachusetts, 02140 | October 3, 1994 | |
Baclofen | Spasticity associated with cerebral palsy | Medtronic, Inc.;800 53rd Avenue N.E., P.O. 1250;Minneapolis, Minnesota, 55440 | September 26, 1994 | |
Monoclonal Ab(murine) anti-idiotype melanoma-associated antigen | Invasive cutaneous melanoma | IDEC Pharmaceuticals Corporation;3030 Callan Road;San Diego, California, 92121 | September 19, 1994 | |
Neurotrophin-1 | Motor neuron disease/amyotrophic lateral sclerosis | Ericsson, Arthur Dale, M.D.;Institute of Biologic Research, 6560 Fannin, Suite 720;Houston, Texas, 77030 | September 13, 1994 | |
Aminosidine | Leishmaniasis | Kanyok, Thomas P. Pharm.D.;University of Illinois at Chicago College of Pharm, 833 South Wood Street (m/c886) Rm. 176;Chicago, Illinois, 60612 | September 9, 1994 | |
Ricin (blocked) conjugated murine monoclonal antibody (CD6) | Cutaneous T-cell lymphomas, acute T-cell leukemia-lymphoma, and related mature T-cell malignancies | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 | September 6, 1994 | |
Somatropin | Adults with growth hormone deficiency | Pharmacia & Upjohn;7000 Portage Road;Kalamazoo, Michigan, 49001 | September 6, 1994 | |
Recombinant vaccinia (human papillomavirus) | Cervical cancer | Xenova Research Limited;310 Cambridge Science Park, Cambridge CB4 OWG; | August 24, 1994 | |
Buffered intrathecal electrolyte/dextrose injection | For use as a diluent in the intrathecal administration of methotrexate and cytarabine for the prevention or treatment meningeal leukemia and lymphocytic lymphoma | Lukare Medical, LLC;4 Julia Court, P. O. Box 782;Scotch Plains, New Jersey, 07076 | August 24, 1994 |